Rural Health Transformation Reality Check: What Rural Hospital Decision-Makers Will Fund in 2026 and What They Won’t
SAN ANTONIO, TX / ACCESS Newswire / February 2, 2026 / Ahead of the AHA Rural Health Care Leadership Conference...
Healthcare
DLA Piper Strengthens Market-leading Corporate Team With Addition of Partner Josh Seidenfeld in Silicon Valley
PALO ALTO--(BUSINESS WIRE)--DLA Piper has welcomed Josh Seidenfeld as Chair of the firm’s Northern California Corporate and Securities practice. Based...
DLA Piper Strengthens Market-leading Corporate Team With Addition of Partner Josh Seidenfeld in Silicon Valley
PALO ALTO--(BUSINESS WIRE)--DLA Piper has welcomed Josh Seidenfeld as Chair of the firm’s Northern California Corporate and Securities practice. Based...
GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite
First worldwide Allia Moveo installation at Hôpital Marie-Lannelongue in France highlights progress in redefining interventional care delivery Allia Moveo combines...
GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite
First worldwide Allia Moveo installation at Hôpital Marie-Lannelongue in France highlights progress in redefining interventional care delivery Allia Moveo combines...
Adia Nutrition Inc. Announces Dr. Brian Browning as Lead Physician for All Orthopedic Treatments and Specialties at Adia Med
Winter Park, Florida--(Newsfile Corp. - February 2, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem...
NanoViricides President Dr. Diwan Interviewed by Mission Matters’ Adam Torres
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026
DALLAS, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence...
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
NeuroThera’s Proprietary Cannabinoid-Enhanced Platform Targets Antibiotic Resistance Using Approved Antimicrobials TEL AVIV, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) -- SciSparc...
MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day
The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in...
MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®
Industry’s Most Studied Placental Allografts Appear in Nearly 100 Clinical and Scientific PublicationsMARIETTA, Ga., Feb. 02, 2026 (GLOBE NEWSWIRE) --...
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd
UNIONDALE, NY, Feb. 02, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”) is pleased to...
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ARS...
Hydreight Technologies Issues Fiscal 2026 Revenue Guidance of ≈ $150 Million and Provides Q1 2026 Outlook
VANCOUVER, British Columbia, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) (“Hydreight” or...
Nova Leap Health Corp. Launches Palliative Care Division In Nova Scotia Through Earth Angels Home Care
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Feb. 02, 2026...
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3...
EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases
New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well...
Groundbreaking therapy for advanced heart failure
Repairon expands to North America to Accelerate Clinical Trials and Product DevelopmentGÖTTINGEN, Germany, Feb. 02, 2026 (GLOBE NEWSWIRE) -- German...
IoT in Healthcare Market to Reach US$594.5 Bn by 2035 at 23.85% CAGR | Vantage Market Research
NEW YORK, Feb. 2, 2026 /PRNewswire/ -- The Global IoT in Healthcare Market is entering a high-impact growth phase as...
NHI Announces $105.5 Million SHOP Investment
MURFREESBORO, TN / ACCESS Newswire / February 2, 2026 / National Health Investors, Inc. (NYSE:NHI) announced today that it invested...